Ambea Q2 FY26 EBITA climbs 32% to SEK 378 million; net sales rise 7% to SEK 4.39 billion

• Ambea Q2 net sales rose 7% to SEK 4.39 billion, while adjusted EBITA climbed 27.65% to SEK 397 million.
• Adjusted EBITA margin widened 1.4 percentage points to 9%, while operating profit (EBIT) increased 28.83% to SEK 353 million.
• Earnings per share more than doubled to SEK 2.13; items affecting comparability totaled SEK -19 million, tied to the Humana offer.
• Recommended public offer launched for Humana, aiming to build a larger Nordic care provider with more scope for investment.
• CEO Mark Jensen cited rising Nordic care demand; the group opened new units, lifted occupancy, and signed new lease agreements.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ambea AB published the original content used to generate this news brief via Cision (Ref. ID: 202608190100BITN____UKPR__EN_20260818-BIT-9094-0) on August 19, 2026, and is solely responsible for the information contained therein.